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PTACHCINSKI, BYRON DELAMOS, SANDY STACHAK, DAVID H. VAN THIEL, SHUNZABURO 
IWATSUKI & THOMAS E. STARZL 
Schools of Pharmacy and Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA 
1 We quantitated the effect of biliary diversion on cyclosporin (CyA) absorption in liver 
transplant patients. Multiple blood samples were obtained over one dosing interval 
following oral CyA administration in eight liver transplant patients before and after T-tube 
clamping. 
2 Cyclosporin concentrations were measured by a high pressure liquid chromatographic 
method. 
3 The mean (± s.d.) dose-normalized area under the blood concentration vs time curve 
(AUC) over a dosing interval was 5.23 (± 3.22) ng ml-1 h during the pre clamping period 
and 15.79 ± 7.92 ng ml- 1 hduring the post clamping period. A significant (P < 0.05) 
increase (276%) in the dose normalized AVC was observed following the T-tube clamping. 
4 Analysis of bile revealed less than 1 mg « 1 % of dose) of unchanged Cy A to be 
eliminated in bile over 12 h. Therefore the .increased CyA AUC/dose following T-tube 
ligation cannot be explained by enterohepatic recirculation. 
5 Increased bile flow secondary to clamping of the T-tube most likely increased the 
absorption of CyA. Increase in CyA absorption may be due to a bile mediated increase in 
CyA solubility or gastrointestinal membrane permeability, or increased residence time at 
the site of absorption. 
6 Independent of the mechanism involved, our results indicate that adjustments in CyA 
. dosage must be made whenever external bile diversion is instituted or discontinued. 
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Introduction 
Orthotopic liver transplantation has become a 
life saving procedure for patients with liver dis-
eases such as biliary atresia, sclerosing cholangitis, 
alcoholic cirrhosis, primary biliary cirrhosis and 
certain metabolic disorders such as ('(j-antitrypsin 
deficiency (Starzl et ai., 1982). The success of 
this procedure is partially due to the use of 
cyclosporin (CyA) in combination with low dose 
steroids to prevent the rejection of the trans-
planted liver. Cyclosporin is a highly lipophilic 
polypeptide of fungal origin. The absorption of 
orally administered CyA is often poor following 
liver transplantation (Burck art et ai., 1986; 
Venkataramanan et al., 1985a). In order to opti-
mize the postoperative care of the transplant 
patients all the factors affecting CyA absorption 
must be completely characterized. 
Liver transplant patients often have aT-tube 
inserted in their common bile duct during surgery . 
Recently, Andrews et ai. (1985) reported a sig-
nificant increase in the trough CyA blood levels 
in liver transplant patients following T-tube 
clamping. Improved enterohepatic recirculation 
of CyA could not account for such an observation 
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since only a very small amount of CyA is excreted 
unchanged in the bile (Venkataramanan et ai., 
1985c). Since CyA is highly lipophilic, its 
absorption may be dependent on the availability 
of bile salts that are removed by biliary diversion. 
Clamping of the T-tube increases the bile flow 
into the gut and therefore may increase CyA 
absorption. In the present study we have quanti-
tated the effect of external bile drainage on CyA 
absorption in liver transplant patients. 
Methods 
Eight adult orthotopic liver transplant recipients 
(two males and six females) with external bile 
drainage participated in the study. Written in-
formed consent was obtained from each patient 
prior to the study. Routine biochemical para-
meters and medication ipiormation were ob-
tained from the patients; medical records. Each 
patient was studied on two separate occasions. 
The first phase was conducted while the patient's 
bile was being drained through the T-tube. In 
this phase of the study, patients were studied 
between days 16 and 30 after the transplant 
surgery. The second phase was conducted after 
clamping the T-tube. All but one study was 
conducted between_ days 1 and 6 after T-tube 
clamping. Patient 6 was studied 68 days after T-
tube clamping. Patients received oral CyA every 
12 h in doses ranging from 500 to 1800 mg day-l 
as part of their postoperative care. On both 
study days blood samples were collected in 
heparinized tubes prior to (0 h) and at 1, 2, 3, 
4, 6, 8, 10, and 12 h following oral CyA (Sand-
immune® oral solution, Sandoz) administration. 
Total bile output through the T-tube was also 
collected over the 12 h period during the first 
phase. Bile samples were centrifuged in an 
Eppendorf centrifuge (model 5412 Brinkman, 
Westbury, NY) for 5 min at 1500 g to separate 
any particulate matter and the clear supernatant 
was diluted 10 fold prior to analysis. Bile and 
whole blood samples were analysed for un-
changed CyA by a high pressure liquid chroma-
tographic (h.p.I.c.) method (Ptachcinski et ai., 
1985a, b). The coefficient of variation (CV%) of 
the assay was 6% for blood and 4% for bile. 
The disposition rate constant (A,z) was esti-
mated from the terminal linear segment of log 
CyA blood concentration vs time profile. The 
area under the Cy A blood concentration vs time 
curve during the dosing interval (AUC(0-12» 
was calculated by trapezoidal method. The area 
under CyA blood concentration vs time curve 
from time 0 to infinity (AUC(0-12» was calcu-
lated for the study dose using the principle of 
reverse superposition (Bauer & Gibaldi, 1983). 
Dose normalized AUCs obtained from the two 
phases of the study were compared using a paired 
t-test at an 0. of 0.05. 
Table 1 Biochemical parameters in patients before and after clamping of the T-tube 
BUN SCR Bili (T) Bili (D) SGOT SGPT 
Patient (mgdrl) (mg%) HCT (mgdlJl) (mgdZ-1) (iu [-I) (iu [-I) 
1 Pre 50 1.3 32.4 3.5 2.1 30 53 
Post 71 1.1 30.9 1.2 0.6 17 20 
2 Pre 62 2.0 34.4 4.4 2.9 33 101 
Post 27 1.4 26.3 1.6 0.9 27 49 
3 Pre 56 2.1 31.8 2.0 1.2 58 174 
Post 73 1.9 33.2 1.0 0.5 17 53 
4 Pre 67 2.4 33.3 5.3 3.3 24 68 
Post 47 1.4 28.7 3.0 1.7 24 49 
5 Pre 77 1.4 34.3 2.7 1.3 22 48 
Post 20 1.6 27.8 0.4 0.1 22 25 
6 Pre 79 2.2 30.1 1.7 1.1 44 161 
Post 60 2.0 29.9 1.5 0.9 48 153 
7 Pre 57 2.2 25.3 2.0 1.7 31 57 
Post 54 1.7 26.9 2.5 1.5 18 62 
8 Pre 44 1.4 32.2 3.0 1.7 17 17 
Post 85 1.8 30.4 2.1 1.2 10 12 
BUN blood urea nitrogen Bili (T) total bilirubin 
HCT haematocrit Bili (D) direct bilirubin 
Results 
The biochemical parameters of the patients before 
and after T-tube clamping are presented in Table 
1. There were no significant differences in trans" 
aminases (SGOT AST; SGPT ALT) , blood urea 
nitrogen (BUN), serum creatinine, haematocrit 
and bilirubin direct (Bili D) concentrations in 
the patients studied during the two phases. Drug 
therapy in patients included CyA, prednisone, 
mycostatin, and hydralazine during both study 
periods. In addition some of the patients received 
frusemide, ranitidine, spironolactone, propra-
nolol, polymyxin, neomycin or murine mono-
clonal antibody or OKT3 (orthoclone, Grtho 
Labs, NJ). 
Figure 1 shows the CyA blood concentration vs 
time profile in patient 4. The pre-clamping and 
post-clamping doses were the same in this patient. 
The blood concentration profile during phase 1 
demonstrated only small differences in the mini-
mum and the maximum blood concentrations. 
Following T-tube clamping, the CyA blood con-
centration increased significantly during the 
dosing interval with well defined maximum and 
minimum blood concentrations. In 63% of the 
studies, the CyA concentration at time 0 and at 
12 h differed by less than 20% indicating the. 
attainment of steady state. The mean (± s.d.) 
disposition half-life of CyA during the phase 1 
was 6.6 h (± 2.8) and was not significantly dif-
ferent from the half-life (5.2 ± 2.2 h) obtained 
during phase 2. Table 2 lists CyA dose, 
AUC(O-oo) and AUC(0-12) per mg of the dose 
in these patients during the two study phases. 
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Figure 1 Cyclosporin blood concentration vs time 
profile in patient 4 receiving the same dose during the 
T-tube open (e) and T-tube closed (0) periods. 
The mean (± s.d.) AUC(0-12) per mg dose 
during phase 1 was 5.23 ng rnI- 1. This was signi-
ficantly lower (P < 0.50) than the value of 15.79 
ng ml- 1 estimated during phase 2. However, the 
extent of increase in the AUC varied widely 
between patients. 
Table 3 shows CyA concentrations in the bile 
obtained during the first phase. Bile could not be 
obtained from patient 6. Compared with blood, 
higher concentrations of CyA were observed in 
the bile samples. However, since the total bile 
output was small (105 to 670 rnI), the amount of 
CyA excreted unchanged in the bile was less 
than 1% of the administered dose in each patient. 
Table 2 Effect of T -tube clamping on cyclosporin absorption 
Pre clamping period Post clamping period 
Dose AUClmg dose Dose AUClmgdose % Increase 
Patient (mg) (ngmr l h) (mg) (ng ml- l h) inAUC 
A B A B A B 
1 600 11.16 11.58 300 26.51 23.63 138 104 
2 800 2.63 3.02 900 10.03 10.08 281 234 
3 600 4.61 2.65 300 26.74 27.21 480 927 
4 350 2.58 2.58 350 13.22 7.48 412 190 
5 600 7.56 7.56 250 17.42 17.42 130 130 
6 600 5,91 3.60 600 6.30 4.89 7 36 
7 800 1.17 0,64 800 7.73 10.63 561 1561 
8 700 6.24 6.24 600 18.40 18.40 195 195 
Mean 5.23 4.73 15.79" 14.97· 276 422 
± ± ± ± ± ± ± 
s.d. 3.22 3.53 7.92 7.96 193 538 
A = based on (AUCb2)ss 
B = based on (AUC) 0 
a Significantly different from preclamping period P < 0.005. 
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Table 3 Biliary excretion of cyclosporin 
Bile CyA bile Amount of 
volume concentration CyAinbile % Dose 
Patient (ml) (j.Lg mrI) 
1 145 4.63 
2 219 0.75 
3 105 1.25 
4 670 0.07 
5 243 1.79 
7 433 0.38 
Discussion 
Cyclosporin inhibits the immune system select-
ively. The selective immunosuppression makes 
it a useful drug for preventing the rejection of 
liver (Starzl et ai., 1981a), kidney (Starzl et ai., 
1981b), heart (Griffith et ai., 1982), and bone 
marrow (Tutschka et ai., 1983) in transplant 
patients. The oral absorption of Cy A in transplant 
patients is erratic and incomplete as indicated by 
its poor bioavailability ranging from 5 to 60% 
with a mean of 30% (Ptacncinski et al., 1986). In 
order to optimize Cy A dosing it is essential to 
characterize factors affecting its absorption. 
Recently, Andrews et ai. (1985) reported that 
clamping or removal of the T-tube leads to 
significantly higher CyA trough levels in liver 
transplant patients. Similar observations have 
been made with digoxin and vitamin BI2 (Car-
ruthers & Dujovne, 1978; Teo et aI., 1980). 
Blood concentrations of drugs which are exten-
sively excreted unchanged in the bile will increase 
following T-tube clamping due to increased 
enterohepatic recycling of the drug. Previous 
studies in our laboratory (Venkataramanan .. et 
ai., 1985c) and the results of the present study 
indicate that very little Cy A is excreted unchanged 
in the bile. Furthermore there is no evidence to 
suggest the presence of a conjugate of CyA in 
the bile that could be reconverted to CyA and 
subjected to enterohepatic recirculation (Maurer 
et aI., 1984). Therefore, enterohepatic recircula-
tion of CyA does not contribute significantly to 
the increase in CyA trough concentration 
following T-tube clamping. 
Bile salts have also been shown to increase 
gastrointestinal absorption of lipophilic drugs by 
enhancing their dissolution, by alteration of the 
gastrointestinal membrane permeability or by 
increasing the residence time of the drug at the 
absorption site. In vitro studies indicate increased 
solubility of Cy A in various bile salts (unpublished 
observation). Bile salts significantly improve the 
absorption of vitamins A (Bernhard et ai., 1952), 
(JJ.g) administered 
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K (Greaves, 1939), and D (Greaves & Schmidt, 
1933) in rats, vitamin D in dogs (Taylor et ai., 
1935) and phenolphthalein in cats (Pekanmaki 
& Salmi, 1961). In man the absorption of fat 
soluble vitamins (A, D, E, and K) is significantly 
impaired in the absence of bile (Forsgren, 1969). 
Diversion of the bile into the gut significantly 
increased the absorption of vitamin BI2 (Teo et 
ai., 1980) and tetracycline (Aukee etal., 1975) in 
patients with aT-tube in their cornmon bile duct. 
Administration of bile salts results in a 50-80% 
increase in the urinary recovery of riboflavin 
in man, indicating improved absorption (Mayer-
schn et ai., 1969). Increased bile flow following 
T-tube clamping could have increased the absorp-
tion of CyA. 
Venkataramanan et ai. (1985b) have observed 
a significant negative correlation between bili-
rubin level and CyA bioavailability. Significant 
impairment in CyA absorption was observed 
only in patients with a total bilirubin of greater 
than 10 mg dl-I. In this study, the highest bili T 
value recorded was 5.3 mg dl- 1 in patient 4 
during phase 1. There was a poor correlation 
(r = -0.05) between the bilirubin levels and the 
CyA AUC values in this study. Therefore, the 
differing bilirubin values in some of our patients 
. is not expected to account for the differences in 
the dose normalized AUCs observed between 
the two phases. 
Recently, Ptachcinski et ai. (1985) have re-
ported increased Cy A absorption in some kidney 
transplant patients when lower divided doses 
were administered as compared with a single 
large dose. In the present study three of the 
patients received the same dose during both 
phases. One patient received a higher dose during 
the second phase but still showed a significant 
increase in the AUC value after T-tube clamping. 
Four patients received a lower dose during the 
post clamping period. Consequently, dose de-
pendent absorption could partially contribute to 
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the observed increase in the AUC in these four 
patients. 
Cyclosporin is distributed in the red blood cell 
in a concentration dependent manner. Robinson 
er al. (1983) have attributed the concentration 
dependent distribution of Cy A in the red blood 
cell to be responsible for the nonlinear relation-
ship between dose and AUC of blood concentra-
tion vs time curve. Concentration dependent 
distribution of CvA between blood cells and 
plasma is seen only above 1000 ng ml- 1 (Nieder-
berger et ai., 1983). In this study less than 1000 
ng ml- 1 of Cy A was present in most (94%) of 
the blood samples. Moreover, concentration 
dependent CyA distribution would only result in 
an underestimation of the effect of bile on CyA 
absorption since the concentrations were higher 
during the phase when bile was emptied com-
pletely into the gut. 
We also evaluated any possible effect of co-
administered drugs on the observed results by 
comparing the patient medication during both 
phases of the study. Four patients received iden-
tical medication during both phases of the study 
which ruled out drug interaction as a Ctiuse of an 
increased AUe.. Two patients received OKT3 
during only one phase of the study. No informa-
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